Seudoquiste pancreático infectado por Shewanella putrefaciens: reporte de caso

Left Knee Septic Monoarthritis in a Pediatric Patient due to Shewanella Putrefaciens: Case Report in Colombia

“…However, susceptibility to ampicillin and cephalosporins is variable, with greater susceptibility to third and fourth-generation cephalosporins than to rst and second generation. (1,3,4,6,9,13,14,18,28) Currently, microbial resistance has increased, especially now that genetic characterization is being carried out, but such characterization in Shewanella remains limited; the latest reported studies mainly characterize phenotypic resistance for clinical management purposes; nding the genes that encode the β-lactamase of oxacillinase class D (blaOXA) that confer resistance to carbapenems and the Plasmid-Mediated Quinolone-Resistance (qnr) Genes that confer resistance to quinolones; establishing intrinsic resistance to carbapenemases and quinolones; it has also been previously shown in vitro that the S. oneidensis Int1-like tyrosine recombinase can form antibiotic resistance integrons; The sulfonamide resistance-conferring genes sul1 and sul2 were detected in S. algae and S. putrefaciens, and the blaOXA-48-like gene was detected only in all three S. putrefaciens isolates. Genomic analyses have shown that some Shewanella spp can harbor between one and three plasmids ranging in size from 16 to 120 kb.…”

“…With varied symptoms in the literature, generating a signi cant impact on human health with a total of 260 disorders described in the literature in the last 40 years, which indicates the potential danger it represents. (2)(3)(4)(5)(6)(7)(8)(9)(10) Shewanella-related infections are reported sporadically, therefore Keyi Yu et al carried out a systematic review of the literature published between 1978 and June 2022, in which cases of Shewanella infection were found throughout the world, with a greater predominance in places with a warm climate or tropical, subtropical and temperate countries, such as Australia, Belgium, Denmark, Israel, Spain, and Turkey; of predominance in cities and coastal regions suitable for tourism and life, such as Taiwan of China, Martinique, Barbados, Canary Islands, with ages ranging from newborns to 92 years, with a predominance in over 60 years and men in 61.7/%, of this 35.16% were infection by S. algae, 28.94% infection by S. putrefaciens and 0.7% infections by S. xiamenensis; isolating mainly in the blood and exudates from skin lesions. In this study, no cases were reported in Colombia, however, when doing a review of the literature, two isolated cases were found in Colombia, none of which occurred in the pediatric population.…”

“…In this study, no cases were reported in Colombia, however, when doing a review of the literature, two isolated cases were found in Colombia, none of which occurred in the pediatric population. (3,11,12) Therefore, we present the clinical case of a pediatric patient with septic monoarthritis of the left knee, infectious by S. Putrefaciens, acquired in the community, in its natural environment.…”

Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective

“…It should be noted that, in addition to the diseases already mentioned, diseases such as diabetes mellitus, peripheral vascular disease, and malignant neoplasms, as well as (drug-induced) immunosuppression, are important risk factors for infection with the described bacterium ( Holt et al., 2005 ; Yilmaz et al., 2007 ; Basir et al., 2012 ; Carlson and Dux, 2013 ; Benaissa et al., 2021 ). Low socioeconomic status, poor personal hygiene, private or occupational exposure to (sea) water, and consumption of contaminated seafood or fish meat also appear to be predisposing factors for development of S. putrefaciens infections ( Otsuka et al., 2007 ; Yilmaz et al., 2007 ; Oh et al., 2008 ; Carlson and Dux, 2013 ; Muñoz et al., 2015 ).…”

“…Due to the expression of β-lactamases, they often show resistance to penicillin, which is frequently used for the treatment of soft tissue infections ( Héritier et al., 2004 ; Vignier et al., 2013 ; Ryan et al., 2018 ). S. putrefaciens is usually susceptible to piperacillin, fluoroquinolones, aminoglycosides and carbapenems ( Vogel et al., 1997 ; Holt et al., 2005 ; Vignier et al., 2013 ; Muñoz et al., 2015 ; Ryan et al., 2018 ; Benaissa et al., 2021 ). It must be kept in mind that Shewanella spp.…”